Table 2.
Selected, clinically validated target genes of AML1/ETO (identified with the use of unbiased screening approaches).
Target gene | Function | Biological process | Reference |
---|---|---|---|
Upregulated | |||
SOX4, IL-17RB, CD200, and JUP (γ-catenin) | Transcription factor, cytokine receptor, anti-inflammatory signal, Adherens junction | Transcriptional regulation, inflammation, cell adhesion | Tonks et al. [61] |
p21waf1 (CDKN1A) | Cyclin-dependent kinase inhibitor | Cell cycle, stem cell maintenance | Berg et al. [59], Peterson et al. [60] |
BCL2a | Anti-apoptotic signal | Apoptosis | Martens et al. [66], Klampfer et al. [119] |
FOXO1 | Transcription factor | Apoptosis, stem cell maintenance | Lin et al. [120] |
GFI1 | Transcriptional repressor | Transcriptional regulation, G1/S-transition, oncogene | Marneth et al. [121] |
TRKA (NTRK1) | MAPK pathway activation, protein kinase | Neuronal development, myeloid differentiation | Mulloy et al. [122] |
ZFP36L1 (ERF-1, TIS11b) | Polypeptide chain release factor | mRNA translation | Shimada et al. [123] |
ARG2, MT2A | Arginine metabolism, metal homeostasis | Immune response, oxidative Stress | Shia et al. [39] |
CD48 | NK-cell mediated immunosurveillance | Adaptive immune response, leukocyte migration | Wang et al. [37] |
CSF3R | Cytokine receptor | Regulation of hematopoiesis | Shimizu et al. [62] |
PAX5 | Transcription factor | B-cell maturation | Tiacci et al. [124] |
POU4F1 | Transcription factor | Transcriptional regulation, B-lymphoid expression | Fortier et al. [125], Dunne et al. [126] |
VLA4 (ITGA4) | Cell adhesion and migration | Leukocyte trafficking, Regulation of hematopoiesis | Ponnusamy et al. [127] |
Downregulated | |||
IL-3 | Cytokine | Regulation of hematopoiesis | Buchi et al. [46] |
CSF2 | Cytokine | Regulation of hematopoiesis | Frank et al. [63] |
CCL3 | Chemokine ligand | Chemotaxis, immune response | Bristow and Shore [128] |
CEBPA | Transcription factor | Regulation of hematopoiesis |
Koschmieder et al. [56] Pabst et al. [57] |
LAT2 | Adaptor molecule | Regulation of hematopoiesis | Fliegauf et al. [47] Duque-Afonso et al. [49, 52]; Essig [50] |
p14ARF (CDKN2A)b | Cyclin-dependent kinase inhibitor | Cell cycle, G1/S-transition, stem cell maintenance | Linggi et al. [64] |
RASSF2 | K-RAS-specific effector protein | Rac GTPase activation, Rac-mediated signal transduction | Stoner et al. [129] |
Lysozyme (LYZ) | Bacteriolytic enzyme | Antimicrobial humoral response, myeloid differentiation | Claus et al. [130] |
OGG1 | DNA repair enzyme | Response to oxidative stress | Liddiard et al. [131] |
PSGL1 (SELPLG) | Cell adhesion and migration | Leukocyte trafficking, regulation of hematopoiesis | Ponnusamy et al. [132] |
NF1 | GTPase-activating protein | Ras signal transduction | Yang et al. [133] |
miR 144/451 | Posttranscriptional regulation | Erythroid differentiation | Kohrs et al. [134] |
SPI1 (PU.1) | Transcription factor | Regulation of hematopoiesis | Vangala et al. [135] |
aIndividual studies have demonstrated downregulation of BCL2 in leukemic cell lines [136].
bReferring to the alternate open reading frame (ARF) which does not function as a CDK4/6 inhibitor.